Australia is a country rich in natural resources and investment opportunities. With its vast landscapes and diverse economy, it provides a compelling environment for both domestic and international investors. In this blog post, we will explore the various resources available in Australia and how they impact investment opportunities across the nation.

Great Boulder Resources Ltd (ASX:GBR) is moving confidently into the second half of 2025. In the span of just two weeks, the Company has expanded the mineralised footprint at Side Well, announced significant new gold intersections at Ironbark, and secured $12.5 million in funding to accelerate its exploration strategy.

Coffee with Samso Episode 207 is all about a company that is feeling left behind in the midst of a unprecedented gold price rush. Gold miners, the producing companies on the ASX, are all buoyant and experiencing an emotional high on valuation. Shareholders are in a state of euphoria but in the rush, there are always some hidden value. The hidden value that is typically brushed aside by the juggernaut of cash producing gold miners speeding past the sights of investors.

Cyclone Metals Limited (ASX: CLE) has released its Quarterly Activities Report for the period ending 30 June 2025, and the momentum behind the Iron Bear Project is evident. Backed by a strategic partnership with Vale S.A., the quarter saw the completion of critical technical studies, advancement in metallurgical testing, progress across engineering and environmental baselines, and tangible steps toward the upcoming Scoping Study and PFS.

The Strategic Importance of Bauxite: Powering the Future of Aluminium - How Do ASX Investors take a Position in the Bauxite Business. The new cold war that is gaining momentum globally is fast creating vast opportunities for jurisdiction hosting commodity projects that have an inelastic demand. Commodities that fall into a real critical supply shortage are all getting a rejuvenation that has been is now making headlines. Commodities such as bauxite are now starting to get

AML3D Limited (ASX: AL3) continues to solidify its reputation as a key enabler of defence manufacturing transformation. Over the June 2025 quarter, the company advanced its “US Scale Up” strategy with concrete progress in strategic partnerships, facility expansion, and order momentum. With a freshly announced order for a portable ARCEMY® system and a strong quarterly cash position of A$30.4 million, AML3D is not just building metal parts, but reshaping how defence manufacturi

Proteomics International Laboratories Ltd (ASX: PIQ), a recognised pioneer in precision diagnostics, has announced a significant development for the Western Australian scientific and medical landscape: a $6 million funding boost to expand the WA Proteomics Facility. This strategic investment will be delivered over three years, with contributions from the WA State Government, Bioplatforms Australia, the University of Western Australia (UWA), and Proteomics International itself

Ausgold Limited (ASX: AUC) has delivered a definitive milestone with the release of its Definitive Feasibility Study (DFS) for the 100%-owned Katanning Gold Project (KGP). The study validates KGP as one of Australia’s most advanced undeveloped open-pit gold projects, combining scale, near-term development potential, and robust economics within a Tier-1 jurisdiction

Coffee with Samso Episode 206 is about how we understand and interact with AI. This episode of Coffee with Samso is asking if we really know what Artificial Intelligence is about ? Are we just taking it for granted the simplicity of the word AI and is it sufficient to just take what people say about about what AI will do for or to us in the coming years.

Mesoblast Limited (ASX: MSB | Nasdaq: MESO) has taken a critical step toward commercialising its lead cardiac product candidate, Revascor® (rexlemestrocel-L), with formal alignment reached with the United States Food and Drug Administration (FDA) on the key requirements for filing a Biologics License Application (BLA) in the treatment of ischemic heart failure with reduced ejection fraction (HFrEF) and inflammation.

NeuroScientific Biopharmaceuticals Ltd (ASX: NSB) has taken a major strategic step by acquiring StemSmart™, a globally patented and clinically validated stem cell platform. This acquisition adds a powerful, next-generation therapeutic capability to the company’s focus on neuroimmune and inflammatory diseases.

30 June 2025 – Lightning Minerals Ltd (ASX: L1M) has announced a transformational acquisition of two advanced brownfields projects targeting gold and copper in Queensland  (Mt Turner Projects) and New South Wales (Lachlan Fold Copper Porphyry Project). The acquisition of Lotus Minerals Pty Ltd significantly strengthens the Company’s portfolio and introduces immediate drill targets in some of Australia’s most mineral-endowed regions.